China Warns Battery Industry Against Overcapacity
By Reuters | 08 Jan, 2026
Surging global demand for storage batteries for new AI data center buildout may override the industry ministry's views with leading Chinese battery makers.
China's industry ministry said on Thursday it had urged battery manufacturers to optimize industry capacity and mitigate risks of overcapacity.
The ministry highlighted the need to regulate market competition and enhance supervision within the electric vehicle and energy storage battery sectors, according to a readout of a meeting on Wednesday posted on its Wechat account.
Top battery makers CATL, BYD, Gotion High Tech and EVE Energy were among the some 16 companies present at the meeting, state-run China Daily reported, citing sources. Energy storage system integrators Beijing HyperStrong Technology, Zhuzhou CRRC Times Electric and Trina Solar - also a top solar manufacturer - also attended, according to the report.
The industry ministry said it convened the meeting along with the state planner and energy and market regulators.
Demand for energy storage batteries has surged as a result of the construction of data centres around the world.
The industry has blindly built out manufacturing capacity, the ministry said, echoing criticism of the solar sector where ballooning capacity led to sinking prices and industry-wide losses.
(Reporting by Colleen Howe; Editing by Jacqueline Wong, Stephen Coates and Louise Heavens)
Recent Articles
- Become an AI Bonus Baby—or Just Get Paid Like One
- Ferrari Denies Requiring Luce EV Purchase to Access to Limited Edition Models
- SpaceX Turns to Bond Sale to Fatten $100.8 Billion Cash Stash
- Google DeepMind Signs AI Research Deal with Film Studio A24
- China's 618 Shopping Festival Sees Flat E-Commerce Sales from Cautious Shoppers
- Amazon Prime Day to Gauge US Consumer Strain as Focus Shifts to Basics
- China Closing in but US Still Leads in Biotech Innovation
- EV Surge Likely to Cut Oil Demand by Late 2027
- Kunal Shah tapped to Lead Meta's WhatsApp
- AbbVie Bets $10.9 Billion on Apogee in Next-Generation Immunology Growth Push
